e-learning
resources
Monograph
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Jessie Huang, Darrell N. Kotton
Source:
Eur Respir Monogr 2021; 91: 205-221
Journal Issue:
Lung Stem Cells in Development, Health and Disease
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Jessie Huang, Darrell N. Kotton. Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease. Eur Respir Monogr 2021; 91: 205-221
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021
Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
Engineering distal pulmonary epithelium from induced pluripotent stem cell (iPSC)-derived alveolar cells
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021
LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Evaluation of cadmium cytotoxicity using alveolar epithelial cells derived from human induced pluripotent stem cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Generation of an immortalized functional alveolar epithelial cell line originating from human induced pluripotent stem cells
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Induced pluripotent stem cell-derived alveolar epithelial cells: applications with lung-on-a-chip
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
LSC - 2018 - Generation of alveolar epithelial cells from human induced pluripotent stem cells for a model of alveolar wound repair
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Embryonic stem cells generate airway epithelium
Source: Eur Respir J 2004; 24: Suppl. 48, 436s
Year: 2004
3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019
Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
Derivation of epithelial-only airway organoids from human pluripotent stem cells
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019
Role of stromal cells during human iPSC differentiation into bronchial epithelium
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept